staceywhite, Author at European Medical Journal - Page 40 of 195

This site is intended for healthcare professionals

Continue
2 Mins
18 Jul 2024

Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Interruption in Hepatitis B Virus/HIV Co-Infected Individuals

Among hepatitis B virus (HBV) core antibody positive (cAb+) people with HIV, suppressive HBV treatment, including either tenofovir…
1 Mins
18 Jul 2024

Barriers and Motivators for Implementation of Lifestyle Changes in Metabolic Dysfunction-Associated Steatotic Liver Disease

Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) experience difficulties in complying with required lifestyle…
2 Mins
18 Jul 2024

TGR5 Deficiency in Liver Sinusoidal Endothelial Cells Disrupts Angiocrine Signalling After Hepatectomy 

Bile acid (BA) receptors like farnesoid X receptor (FXR) and TGR5 have been implicated in liver regeneration.
7 Mins
18 Jul 2024

EASL 2024 Abstract Highlights

The following highlights spotlight the latest research in hepatology, featuring studies presented at this year’s EASL Congress….
16 Jul 2024

Gilead Prevention Symposium at AIDS 2024

Improved HIV prevention awareness, education, and access are essential for protecting those who might benefit and helping tackle the…
2 Mins
16 Jul 2024

Burnout and Professional Fulfilment in a Hematology/Oncology Fellowship Program

Burnout is widespread in medicine, with up to 60% of oncologists and 20% of oncology fellows in the USA reporting burnout. Currently…
16 Jul 2024

AMJ Oncology is out now!

The inaugural edition of AMJ Oncology delivers insights into the future of the field with detailed coverage of the 2024 ASCO Annual Meeting.
1 Mins
16 Jul 2024

Early Palliative Care Among Patients Recently Diagnosed with Advanced Cancers

Early integration of palliative care (PC) is recommended for advanced cancers given its clinical benefits for quality of life and survival…
2 Mins
16 Jul 2024

ASCO 2024 Interview: Michael A. Postow

Immunotherapy with drugs like nivolumab and ipilimumab has been decades in the making, even long before our group at MSK was involved. The…
7 Mins
15 Jul 2024

‘IMROZ’ Study – Clinical Implications

Despite what Mohty described as “progressive advances in the field” over recent years, significant unmet needs remain in the front-line…
We’ve noticed you’re accessing
from North/South America.